- Exchange: Tel Aviv
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Snapshot for Perrigo Co (PRGO)
| Open: | 43,500.00 | Day's Range: | 43,420.00 - 43,800.00 | Volume: | 19,963 |
|---|---|---|---|---|---|
| Previous Close: | 43,870.00 | 52wk Range: | 36,710.00 - 47,480.00 | 1-Yr Rtn: | +14.05% |
Key Statistics for PRGO
| Current P/E Ratio (ttm) | 23.2081 |
|---|---|
| Estimated P/E(06/2013) | 21.1514 |
| Relative P/E vs. TA-100 | 520.8985 |
| Earnings Per Share (USD) (ttm) | 5.1300 |
| Est. EPS (USD) (06/2013) | 5.6190 |
| Est. PEG Ratio | 1.7465 |
| Market Cap (M ILS) | 40,786.46 |
| Shares Outstanding (M) | 93.55 |
| 30 Day Average Volume | 35,693 |
| Price/Book (mrq) | 5.0347 |
| Price/Sale (ttm) | 3.2792 |
| Dividend Indicated Gross Yield | 0.30% |
| Cash Dividend (USD) | 0.0900 |
| Last Dividend | 05/31/2013 |
| 5 Year Dividend Growth | 12.15% |
| Next Earnings Announcement | 08/16/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PRGO
Company Profile & Key Executives for PRGO
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes OTC and generic prescription pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients and pharmaceutical and medical diagnostic products. The Company's primary markets and locations of manufacturing and logistics operations are the US, UK, Mexico, and Australia.
| Joseph C Papa "Joe"Chairman/CEO | Judy L BrownExec VP/CFO |
| Todd W KingmaExec VP/Secy/General Counsel | Douglas Boothe "Doug"Exec VP/General Manager |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PRGO News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page